{"preliminary_commentary":{"by_channel":{"x_thread":3},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":false},"commentary_summary":null,"drugs_tested":[],"indication":"high-risk stage I non-small cell lung cancer","name":"NCT01336894","nct_id":"NCT01336894","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=nct01336894. The price is an estimate of verified statements from the commentary indexed so far. Final coverage is set when the report is built. You never pay more than quoted: if the report is delivered at a smaller size, you pay that size's price, and anything paid above it is refunded. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_rule":"Never more than quoted: the buyer pays the smaller of price_usd and the price the delivered edition is sold at.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Patients undergo sublobar resection comprising either a wedge resection or anatomical segmentectomy with or without intraoperative brachytherapy comprising an iodine I 125 implant at the resection margin.","label":"Arm I (SR+Brachytherapy)","type":"ACTIVE_COMPARATOR"},{"description":"Patients undergo 3 fractions of stereotactic body radiation therapy at 2-8 days apart.","label":"Arm II (SBRT)","type":"EXPERIMENTAL"}],"collaborators":["National Cancer Institute (NCI)"],"completion_date":{"date":"2017-03-27","type":"ACTUAL"},"conditions":["Lung Cancer"],"enrollment":{"count":13,"type":"ACTUAL"},"has_results":true,"interventions":[{"name":"therapeutic conventional surgery","otherNames":[],"type":"PROCEDURE"},{"name":"iodine I 125","otherNames":[],"type":"RADIATION"},{"name":"stereotactic body radiation therapy","otherNames":[],"type":"RADIATION"}],"last_update":"2017-05-30","lead_sponsor":"Alliance for Clinical Trials in Oncology","official_title":"A Randomized Phase III Study of Sublobar Resection (+/- Brachytherapy) Versus Stereotactic Body Radiation Therapy in High Risk Patients With Stage I Non-Small Cell Lung Cancer (NSCLC)","overall_status":"TERMINATED","phases":["PHASE3"],"primary_completion_date":{"date":"2013-05","type":"ACTUAL"},"primary_outcomes":[{"measure":"3-year Overall Survival (OS) Rate","timeFrame":"Up to 3 years post-randomization"}],"references":[{"citation":"Fernando HC, Timmerman R. American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: a randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2012 Sep;144(3):S35-8. doi: 10.1016/j.jtcvs.2012.06.003. Epub 2012 Jul 11.","pmid":"22795435","type":"RESULT"}],"start_date":{"date":"2011-05"},"study_type":"INTERVENTIONAL","title":"Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer","url":"https://clinicaltrials.gov/study/NCT01336894"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.2","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/nct01336894"}